Last updated: April 26, 2023
Sponsor: N/A
Overall Status: Active - Recruiting
Phase
N/A
Condition
Mild Cognitive Impairment
Alzheimer's Disease
Treatment
N/AClinical Study ID
TX284506
online_IRB-19-01509
Ages 55-100 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Must have study partner
- English speaking
- No verbal impairment
- Community dwelling
- Must have webcam or smartphone
Exclusion
Exclusion Criteria:
*
Study Design
Study Start date:
Estimated Completion Date:
January 31, 2025
Study Description
Connect with a study center
Icahn School of Medicine at Mount Sinai
New York City, New York 10029
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.